CC
CLVS
Casdin Capital’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-235,000
| Closed | -$6.9M | – | 38 |
|
|
2018
Q3 | $6.9M | Buy |
235,000
+15,000
| +7% | +$441K | 0.84% | 28 |
|
|
2018
Q2 | $10M | Buy |
220,000
+42,500
| +24% | +$1.93M | 1.4% | 24 |
|
|
2018
Q1 | $9.37M | Buy |
177,500
+50,000
| +39% | +$2.64M | 1.65% | 22 |
|
|
2017
Q4 | $8.67M | Hold |
127,500
| – | – | 2.11% | 19 |
|
|
2017
Q3 | $10.5M | Sell |
127,500
-2,500
| -2% | -$206K | 2.97% | 17 |
|
|
2017
Q2 | $12.2M | Buy |
130,000
+107,000
| +465% | +$10M | 4.5% | 8 |
|
|
2017
Q1 | $1.46M | Buy |
+23,000
| New | +$1.46M | 0.86% | 27 |
|
|
2016
Q4 | – | Sell |
-110,000
| Closed | -$3.97M | – | 29 |
|
|
2016
Q3 | $3.97M | Sell |
110,000
-40,000
| -27% | -$1.44M | 3.21% | 12 |
|
|
2016
Q2 | $2.06M | Buy |
+150,000
| New | +$2.06M | 2.05% | 17 |
|